Recent News

• 11.13.2024 - BioSig Regains Compliance with Nasdaq’s Minimum Bid Price Requirement
• 11.13.2024 - BioSig Regains Compliance with Nasdaq’s Minimum Bid Price Requirement
• 10.22.2024 - BioSig Technologies’ Common Stock to Resume Trading on the NASDAQ Exchange, Wednesday, October 23, 2024 After Its Successful Appeal to the NASDAQ Panel

Recent Filings

• 01.15.2025 - 3 Initial statement of beneficial ownership of securities
• 01.13.2025 - S-8 Securities to be offered to employees in employee benefit plans
• 12.31.2024 - 8-K Current report
• 12.18.2024 - 8-K Current report
• 12.18.2024 - 424B5 Prospectus [Rule 424(b)(5)]
• 12.17.2024 - EFFECT Notice of Effectiveness
• 12.13.2024 - CORRESP Correspondence
• 12.09.2024 - S-3/A Registration statement under Securities Act of 1933
• 12.06.2024 - 8-K Current report
• 11.18.2024 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material